Research Paper Volume 15, Issue 17 pp 8744—8769
Comprehensive analysis and experimental validation reveal elevated CLCN4 is a promising biomarker in endometrial cancer
Figure 2. Association of CLCN4 with OS in pan-cancer. (A) The correlation between CLCN4 expression and OS in various tumors used cox regression model. (B–D) Kaplan-Meier curve of KIRC, MESO, UCEC.